| 0 (0%) | 07-26 12:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 36.76 | 1-year : | 37.35 |
| Resists | First : | 31.47 | Second : | 31.97 |
| Pivot price | 30.96 |
|||
| Supports | First : | 30.65 | Second : | 25.5 |
| MAs | MA(5) : | 31.03 |
MA(20) : | 30.95 |
| MA(100) : | 30.21 |
MA(250) : | 29.19 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 40.2 |
D(3) : | 57.7 |
| RSI | RSI(14): 63.5 |
|||
| 52-week | High : | 31.97 | Low : | 27.73 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ PBAP ] has closed Bollinger Bands are 22.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 31.18 - 31.36 | 31.36 - 31.52 |
| Low: | 30.66 - 30.89 | 30.89 - 31.11 |
| Close: | 30.8 - 31.13 | 31.13 - 31.44 |
Mon, 13 Jul 2026
PBAP ETF Profile: Dividends, Returns (CBOE:PBAP) - TradingView
Fri, 03 Jul 2026
Trading the Move, Not the Narrative: (PBAP) Edition - Stock Traders Daily
Tue, 23 Jun 2026
(PBAP) Volatility Zones as Tactical Triggers - Stock Traders Daily
Tue, 17 Feb 2026
A Designer “Bridge” Molecule to Enhance Existing Cancer Immunotherapies - the-scientist.com
Wed, 11 Feb 2026
New strategy harnesses pre-existing antiviral immunity to boost anti-tumor responses - News-Medical
Tue, 12 Nov 2024
PBAP Stock Fund Price and Chart — CBOE:PBAP - TradingView
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|